Cargando…
Correction: Clinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapy
Autores principales: | Raje, Noopur, Mateos, María-Victoria, Iida, Shinsuke, Reece, Donna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322818/ https://www.ncbi.nlm.nih.gov/pubmed/37407575 http://dx.doi.org/10.1038/s41408-023-00866-y |
Ejemplares similares
-
Clinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapy
por: Raje, Noopur, et al.
Publicado: (2023) -
Panobinostat and Multiple Myeloma in 2018
por: Yee, Andrew J., et al.
Publicado: (2018) -
How We Approach Smoldering Multiple Myeloma
por: Raje, Noopur, et al.
Publicado: (2020) -
Bone Disease in Multiple Myeloma: Biologic and Clinical Implications
por: Bernstein, Zachary S., et al.
Publicado: (2022) -
Treatment of Smoldering Multiple Myeloma: Ready for Prime Time?
por: Kim, E. Bridget, et al.
Publicado: (2020)